CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 2004 Publications

1-10  

 

11. Watchful Waiting and Factors Predictive of Secondary Treatment of Localized Prostate Cancer.
Wu H, Sun L, Moul JW, Wu HY, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D.
J Urol, Vol 171(3) March 2004 pp 1111-1116
Abstract

 

12. Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy.
Moul JW et al:
J Urol, Vol 171(3) March 2004 pp 1141-1147
Abstract

 

13. PSA-based biomarker for predicting mortality in prostate cancer.
Moul JW et al:
Am J of Urol Rev, 2(6):271-277, 2004.

 

14.Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy.
Amling, Christopher L.; Riffenburgh, Robert H.; Sun, Leon; Moul, Judd W.; Lance, Raymond S.; Kusuda, Leo; Sexton, Wade J.; Soderdahl, Douglas W.; Donahue, Timothy F.; Foley, John P.; Chung, Andrew K.; McLeod, David G.:
Jour of Clin Oncology, Vol 22(3) 1 February 2004 pp 439-445
 Abstract

 

15. Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
Grizzle WE, Adam BL, Bigbee WL, Conrads TP, Carroll C, Feng Z, Izbicka E, Jendoubi M, Johnsey D, Kagan J, Leach RJ, McCarthy DB, Semmes OJ, Srivastava S, Srivastava S, Thompson IM, Thornquist MD, Verma M, Zhang Z, Zou Z.
Dis Markers. 2003-2004;19(4-5):185-95.
 Abstract | PDF